28.3 C
Vientiane
Wednesday, September 17, 2025
spot_img
Home Blog Page 28

OROJIN™️ Makes Global Debut at BIOHK 2025 to Lead The Future of Preventive Medicine

Breakthrough Chewable Chlorogenic Acid Tablet Designed To Support Immunity, Cellular Vitality and Metabolism.


HONG KONG SAR – Media OutReach Newswire – 15 September 2025 – OROJIN™️, the breakthrough oral chewable tablet system was unveiled at BIOHK 2025, one of the world’s most influential biotechnology gatherings. Signalling the beginning of a new era in preventive medicine, OROJIN™️ was created to redefine the way people approach their health. More than a supplement, OROJIN™️ delivers a daily dose of chlorogenic acid, a powerful antioxidant that supports immunity, cellular vitality, and promotes metabolic harmony. A “Daily Act of Self-Respect”, OROJIN™️ empowers people everywhere to live stronger, healthier, and more fulfilled lives.

OROJIN™️ Makes Global Debut at BIOHK 2025 to Lead The Future of Preventive Medicine

Science That Protects

Developed in collaboration with leading professors and medical pioneers from the Miskawaan Health Group (MHG) and Jiuzhang Biotech, OROJIN™️ is built on advanced research into chlorogenic acid, one of nature’s most potent antioxidant compounds. Extracted from Eucommia leaves using a comprehensive, proprietary system, its researched benefits include:

  • Neutralizing free radicals that damage DNA and accelerate aging. 1
  • Calming chronic inflammation, the root cause of many diseases.2
  • Restoring healthy cell signalling and boosting natural energy transport in the body, leading to beneficial metabolic effects. 3
  • Protecting vital organs, including the heart, liver, gut, and brain. 4
  • Encouraging restful sleep, and supporting memory and focus. 5

A New Standard in Preventive Medicine

With OROJIN™️, science becomes simple, accessible, and actionable in everyday life. “OROJIN™️ is not just another product — it is the beginning of a movement,” said David Boehm, Chairman of OROJIN™️ and Miskawaan Health Group. “This launch represents a mindset shift, encouraging people to take a proactive interest and care in their own health and wellbeing journey. We are delighted to be part of a new and empowered approach to wellness that starts with daily proactive care,” he added.

Global Launch Celebration at BIOHK 2025

The launch celebrations were led by David Boehm, Chairman of OROJIN™️, and Miskawaan Health Group, and Zhang Jie, Founder and Chairman of Jiuzhang Biotech. They included a Ribbon Cutting Ceremony featuring the OROJIN PreventaPanda™️, a beloved symbol of proactive health.

References

  1. Ogawa H, et al. Chem Lett. 2023;52:524-527.
  2. Huang J, et al. Front Pharmacol. 2023 Sep 13:14:1218015.
  3. Meng S, et al. Evid Based Complement Alternat Med. 2013:2013:801457.
  4. Lu H, et al. Compr Rev Food Sci Food Saf. 2020;19:3130-3158.
  5. Saitou K, et al. Nutrients. 2018;10:1337.

Disclaimer: This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.
Hashtag: #OROJIN

The issuer is solely responsible for the content of this announcement.

About OROJIN™️

is the world’s first complete preventive wellness system, built on decades of scientific research and inspired by the belief that prevention is the highest form of care. Designed for global impact, OROJIN™️ empowers individuals everywhere to live longer, stronger, and with self-respect.

About Miskawaan Health Group

Miskawaan Health Group (MHG) combines cutting-edge German medical diagnostics with the wisdom of traditional holistic healing practices. The mission: to integrate the latest advancements in medical science with natural therapies to deliver personalised, patient-centred care.

About Jiuzhang Biotech

Jiuzhang Biotech is a pioneer in botanical medicine and natural product research. With more than 80 patents in proprietary extraction technologies, the company integrates traditional Chinese medicine with modern biotechnology to deliver pharmaceutical-grade raw materials and science-backed wellness solutions.

OROJIN™️ Makes Global Debut at BIOHK 2025 to Lead The Future of Preventive Medicine

Breakthrough Chewable Chlorogenic Acid Tablet Designed To Support Immunity, Cellular Vitality and Metabolism.


HONG KONG SAR – Media OutReach Newswire – 15 September 2025 – OROJIN™️, the breakthrough oral chewable tablet system was unveiled at BIOHK 2025, one of the world’s most influential biotechnology gatherings. Signalling the beginning of a new era in preventive medicine, OROJIN™️ was created to redefine the way people approach their health. More than a supplement, OROJIN™️ delivers a daily dose of chlorogenic acid, a powerful antioxidant that supports immunity, cellular vitality, and promotes metabolic harmony. A “Daily Act of Self-Respect”, OROJIN™️ empowers people everywhere to live stronger, healthier, and more fulfilled lives.

OROJIN™️ Makes Global Debut at BIOHK 2025 to Lead The Future of Preventive Medicine

Science That Protects

Developed in collaboration with leading professors and medical pioneers from the Miskawaan Health Group (MHG) and Jiuzhang Biotech, OROJIN™️ is built on advanced research into chlorogenic acid, one of nature’s most potent antioxidant compounds. Extracted from Eucommia leaves using a comprehensive, proprietary system, its researched benefits include:

  • Neutralizing free radicals that damage DNA and accelerate aging. 1
  • Calming chronic inflammation, the root cause of many diseases.2
  • Restoring healthy cell signalling and boosting natural energy transport in the body, leading to beneficial metabolic effects. 3
  • Protecting vital organs, including the heart, liver, gut, and brain. 4
  • Encouraging restful sleep, and supporting memory and focus. 5

A New Standard in Preventive Medicine

With OROJIN™️, science becomes simple, accessible, and actionable in everyday life. “OROJIN™️ is not just another product — it is the beginning of a movement,” said David Boehm, Chairman of OROJIN™️ and Miskawaan Health Group. “This launch represents a mindset shift, encouraging people to take a proactive interest and care in their own health and wellbeing journey. We are delighted to be part of a new and empowered approach to wellness that starts with daily proactive care,” he added.

Global Launch Celebration at BIOHK 2025

The launch celebrations were led by David Boehm, Chairman of OROJIN™️, and Miskawaan Health Group, and Zhang Jie, Founder and Chairman of Jiuzhang Biotech. They included a Ribbon Cutting Ceremony featuring the OROJIN PreventaPanda™️, a beloved symbol of proactive health.

References

  1. Ogawa H, et al. Chem Lett. 2023;52:524-527.
  2. Huang J, et al. Front Pharmacol. 2023 Sep 13:14:1218015.
  3. Meng S, et al. Evid Based Complement Alternat Med. 2013:2013:801457.
  4. Lu H, et al. Compr Rev Food Sci Food Saf. 2020;19:3130-3158.
  5. Saitou K, et al. Nutrients. 2018;10:1337.

Disclaimer: This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.
Hashtag: #OROJIN

The issuer is solely responsible for the content of this announcement.

About OROJIN™️

is the world’s first complete preventive wellness system, built on decades of scientific research and inspired by the belief that prevention is the highest form of care. Designed for global impact, OROJIN™️ empowers individuals everywhere to live longer, stronger, and with self-respect.

About Miskawaan Health Group

Miskawaan Health Group (MHG) combines cutting-edge German medical diagnostics with the wisdom of traditional holistic healing practices. The mission: to integrate the latest advancements in medical science with natural therapies to deliver personalised, patient-centred care.

About Jiuzhang Biotech

Jiuzhang Biotech is a pioneer in botanical medicine and natural product research. With more than 80 patents in proprietary extraction technologies, the company integrates traditional Chinese medicine with modern biotechnology to deliver pharmaceutical-grade raw materials and science-backed wellness solutions.

Home Control (1747.HK) Announces Strategic Expansion into Healthcare Sector; Leveraging multi-disciplinary technologies which might include AIoT, Web3, expecting a potential increase in valuation

HONG KONG, Sept. 15, 2025 /PRNewswire/ — On 12 September, Home Control (1747.HK) announced a strategic expansion into the healthcare sector with plans to establish a wholly owned subsidiary in Hong Kong. The new entity will focus on incubating and integrating smart healthcare hardware, with the aim of building a people-centric health services ecosystem. Market observers expect the initiative to leverage multi-disciplinary technologies such as AIoT, Web3, digital assets and Real World Assets Tokenization (RWA), which could serve as catalysts for a potential re-rating of the Company’s valuation.

Platform Development Through Technology Integration

Home Control is prioritizing innovation by combining in-house R&D with integrated solutions designed for smart home healthcare settings. Its goal is to create a one-stop health management platform that aligns with global demands over the digital transformation of healthcare systems and secure data management. Research indicates that modernization of healthcare data and the establishment of resilient technology infrastructure require the application of cloud computing, generative AI and related emerging technologies. The convergence of AIoT, Web3 and RWA with healthcare is widely viewed as a natural extension of the Company’s strategy.

To support these ambitions, Home Control has strengthened its Board. Newly appointed Independent Non-Executive Director Mr. Ye Min previously served as Managing Director and Head of International Business at Moody’s, and as Chief Executive Officer of China Chengxin International (CCXI), the country’s first nationwide credit rating agency. With deep expertise in Web3 finance, risk management and ESG, Mr. Ye is expected to provide strategic and compliance insights as the Company advances into healthcare.

Strategic resources in the Asian healthcare market

Another new Independent Non-Executive Director, Mr. Chen Yi Chung, adds significant regional healthcare experience. Through OUE Group, a Singapore-listed healthcare and property group, he has overseen investments and operations across Asia. OUE’s healthcare subsidiary, Healthway, runs over 130 clinics and medical centers in Singapore, with an expanding footprint in China, Myanmar, Indonesia and Japan. Key milestones include the operation of a hospital in Myanmar (2019), the establishment of an international medical centre in Shenzhen in partnership with the Chinese University of Hong Kong (2023), and the acquisition of a leading Singapore physiotherapy provider (2024). Mr. Chen’s expertise and network are expected to be highly complementary to Home Control’s healthcare ambitions.

Bridging Gaps in the Global Healthcare Ecosystem with Extensive Resources

Healthcare data is growing rapidly — at an estimated CAGR of 36% from 2020 to 2025 — yet infrastructure and integration remain underdeveloped. These barriers have discouraged many private enterprises from entering the sector. By proposing the creation of a global healthcare services ecosystem, Home Control is aiming to address these gaps by bridging data flows between households and clinics and exploring new healthcare delivery models.

The Company’s vision is to create a people-focused healthcare network that connects device makers, healthcare service providers, insurers and other stakeholders. Such integration requires advanced technology, strong relationships and deep market insight. Market commentators note that Home Control’s increasingly proactive communication of its strategy signals the depth of resources backing its ambitions.

Earlier this year, the Company appointed Ms. Ma Ying as a Non-Executive Director. Ms. Ma co-founded the Zhejiang Jack Ma Public Welfare Foundation in 2014 and served as its Chairman and Legal Representative. Her profile in philanthropy and education, along with her ties to leading figures in China’s new economy, have fuelled market expectations that she could play a supportive role in Home Control’s future healthcare expansion.

Global Healthcare at a Digital Inflection Point, showcasing tremendous opportunities

Industry consensus suggests that global healthcare systems are at a tipping point where digitalization is no longer optional but urgent. Deloitte’s 2025 Global Healthcare Outlook highlights that leaders in markets such as the US, UK, Germany, Canada, the Netherlands and Australia are prioritizing digital transformation and investing heavily in healthcare as a high-growth sector. Against this backdrop, Home Control’s entry into healthcare — supported by new Board members with expertise in Web3, finance and medical services — positions the Company to capture a meaningful share of this emerging growth opportunity.

Luang Prabang to Celebrate That Chomsi Stupa Ceremony This October

Chonsi Stupa in Luang Prabang Province (Photo: Encircle) Photos

Luang Prabang is set to host the That Chomsi Stupa ceremony from 5 to 6 October, celebrating the city’s cultural traditions and the stupa’s spiritual significance. 

BCI Shines at the RE+2025 Energy Expo in Las Vegas

LAS VEGAS, Sept. 15, 2025  /PRNewswire/ — BCI, an Indonesian solar cell manufacturer, achieved remarkable success at the 2025 RE+ Expo held in Las Vegas from September 8-11. As North America’s largest clean energy platform, RE+ brought together global industry leaders, where BCI (PT.BINTAN CELLULAR INDONESIA) BCI demonstrated its technological prowess in solar cells and established valuable partnerships.


The BCI booth was always crowded with visitors. BCI comprehensively displayed its product lines covering high-efficiency cells and next-generation ultra-high-efficiency technologies. Its full range of photovoltaic cells have won wide acclaim from the professional audience with their ultra-high conversion efficiency, ultra-low energy consumption design and excellent temperature coefficient performance. It is worth noting that the core products have passed a number of international authoritative tests and comply with the compliance guidelines of the North American market, providing local customers with a reliable option for quick landing.

The event generated overwhelming industry interest in BCI. Numerous potential clients engaged in in-depth discussions, expressing strong cooperation intentions. This enthusiastic response validates BCI’s technological strengths and market competitiveness in the global renewable energy sector.

BCI remains committed to driving the clean energy transition through continuous innovation. Leveraging our manufacturing base in Indonesia, we are actively strengthening the connection between Southeast Asian production capacity and the North American market. Moving forward, BCI will collaborate with global photovoltaic partners to contribute to a sustainable energy future worldwide.

BCI Shines at the RE+2025 Energy Expo in Las Vegas

LAS VEGAS, Sept. 15, 2025  /PRNewswire/ — BCI, an Indonesian solar cell manufacturer, achieved remarkable success at the 2025 RE+ Expo held in Las Vegas from September 8-11. As North America’s largest clean energy platform, RE+ brought together global industry leaders, where BCI (PT.BINTAN CELLULAR INDONESIA) BCI demonstrated its technological prowess in solar cells and established valuable partnerships.


The BCI booth was always crowded with visitors. BCI comprehensively displayed its product lines covering high-efficiency cells and next-generation ultra-high-efficiency technologies. Its full range of photovoltaic cells have won wide acclaim from the professional audience with their ultra-high conversion efficiency, ultra-low energy consumption design and excellent temperature coefficient performance. It is worth noting that the core products have passed a number of international authoritative tests and comply with the compliance guidelines of the North American market, providing local customers with a reliable option for quick landing.

The event generated overwhelming industry interest in BCI. Numerous potential clients engaged in in-depth discussions, expressing strong cooperation intentions. This enthusiastic response validates BCI’s technological strengths and market competitiveness in the global renewable energy sector.

BCI remains committed to driving the clean energy transition through continuous innovation. Leveraging our manufacturing base in Indonesia, we are actively strengthening the connection between Southeast Asian production capacity and the North American market. Moving forward, BCI will collaborate with global photovoltaic partners to contribute to a sustainable energy future worldwide.

Aloft Surabaya Pakuwon City Debuts as East Surabaya’s Newest MICE Destination

SURABAYA, Indonesia, Sept. 15, 2025 /PRNewswire/ — Aloft Surabaya Pakuwon City, the first Aloft in Surabaya and part of Marriott International, introduces a fresh destination for meetings, incentives, conferences, and exhibitions (MICE) in East Surabaya. Designed for today’s business and social events, the hotel features expansive, tech-ready venues complemented by bold design and lifestyle-driven hospitality.

Bold, tech-ready and versatile, Aloft Surabaya’s meeting spaces redefine East Surabaya’s MICE scene with style and functionality.
Bold, tech-ready and versatile, Aloft Surabaya’s meeting spaces redefine East Surabaya’s MICE scene with style and functionality.

Connected directly to Pakuwon City Mall, the city’s largest lifestyle complex, the hotel offers unmatched convenience for business delegates. Its location also provides quick access to Kenjeran Beach, the Suramadu Bridge, and Juanda International Airport, making it a practical choice for both domestic and international travelers.

Flexible Spaces for Every Occasion

The property’s seven Tactic rooms feature modern design, colorful details, and adaptable layouts that inspire creativity. The ballroom spans 489 square meters with high ceilings, a generous pre-function foyer, and advanced audiovisual support. From product launches and conferences to weddings and exhibitions, every event can be tailored with a modern edge.

“As much as Aloft is about bold design and expressive energy, this hotel is also built for the business community,” said Reza Aryawarman, Multi-Property General Manager of Pakuwon Portfolio Hotels under Marriott International. “We’re proud to introduce a new MICE destination in East Surabaya, with facilities that cater to corporate and social events of every scale.”

True to the Aloft brand, the hotel combines business with lifestyle. Delegates can enjoy Asian comfort food with a modern twist at Vibe Restaurant, unwind over live music and cocktails at Echo Lounge & Bar, or connect casually at W XYZ® bar. For quick bites at any hour, Re:fuel by Aloft® keeps energy flowing 24/7.

Local Story, Global Energy

Adding a Surabaya twist, the hotel introduces mascots Elzo (Electric-Zone) and Keppy (Kepo and Happy), creative reinterpretations of the city’s folklore icons, Sura and Baya. Originating from the mural series “Merasa Bahagia” by Surabaya-born artist Peter Rhian (Redmiller Blood), the characters now appear in murals, digital art, and limited-edition merchandise, bringing local identity into a global stage.

The hotel features 233 loft-inspired guest rooms and suites, equipped with platform beds, walk-in showers, and 55-inch smart TVs. Smart layouts and modern amenities make the rooms ideal for both work and relaxation. Above each bed, variations of the “Merasa Bahagia” mural add a vibrant design detail, while large windows showcase views of Surabaya’s skyline, Kenjeran Beach, or the Suramadu Bridge.

Aloft Surabaya Pakuwon City proudly participates in Marriott Bonvoy®, Marriott International’s award-winning travel program. Members earn and redeem points for stays at more than 30 brands worldwide, unlocking exclusive benefits and curated experiences.

Bookings and event inquiries are now open at www.aloftsurabayapakuwoncity.com.

About Marriott Bonvoy®

Marriott Bonvoy, Marriott International’s award-winning travel platform, connects travelers to the people, places, and passions they love through an extraordinary collection of hotels and experiences worldwide. The platform features over 30 hotel brands and 10,000 destinations, including the largest collection of luxury offerings, distinctive boutique properties, premium home rentals, and more, providing renowned hospitality across the globe. With unrivaled access to the best in entertainment, culinary, sports, outdoor adventure, arts, culture, and more, Marriott Bonvoy offers transformative travel experiences that leave a lasting impression.

Marriott Bonvoy membership is free and unlocks unique benefits including the ability to earn points through travel and everyday activities, like purchases with co-branded credit cards. Members can redeem their points for free stays, experiences and more. Visit marriottbonvoy.com for more information and download the Marriott Bonvoy app here. Travelers can connect with Marriott Bonvoy on Instagram, TikTok, YouTube, and Marriott Bonvoy Insiders.

About Pakuwon Group

Pakuwon Group is one of Indonesia’s leading real estate developers, known for its visionary approach in shaping urban living through integrated developments. With over four decades of experience, Pakuwon has built an impressive portfolio of mixed-use superblocks combining retail, residential, office, and hospitality components across key cities in Indonesia. The Group owns and operates landmark developments such as Tunjungan Plaza and Pakuwon Mall in Surabaya, Gandaria City in Jakarta, and Pakuwon Mall Jogja. In hospitality, Pakuwon continues to expand its presence with a growing collection of award-winning hotels under renowned international brands including Sheraton, The Westin, Four Points, Fairfield, and Marriott Hotels in Jakarta, Surabaya, Bali, Yogyakarta, and Bekasi. Pakuwon is committed to delivering impactful destinations that enhance the way people live, work, shop, and stay. For more information, visit www.pakuwonjati.com.

About Aloft Hotels®

With over 230 hotels now open in 33 countries and territories around the world, Aloft Hotels provides a forward-thinking hotel experience that helps guests enjoy the things they love while on the road. From gaming to cocktails and pet-friendly amenities, the brand offers flexibility with modern, welcoming spaces that encourage social interaction. The grab-and-go breakfast concept Re:fuel by Aloft® includes offerings such as cold brew coffee and breakfast sandwiches, while the W xyz bar features a vibrant social scene, unique music-inspired cocktail menu and easy-to-share light bites. The brand’s pet-friendly program ArfSM (Animals R Fun) welcomes guests’ furry friends to the hotel with special in-room pet amenities. Aloft connects people and places through local know-how and cultural nods that give guests the ultimate freedom to choose their own adventure. For more information, visit www.alofthotels.com and follow along on Facebook, X, and Instagram. Aloft is proud to participate in Marriott Bonvoy®, the global travel program from Marriott International. The program offers members an extraordinary portfolio of global brands, exclusive experiences on Marriott Bonvoy Moments, and unparalleled benefits including free nights and Elite status recognition. To enroll for free or for more information about the program, visit marriottbonvoy.com.

FOMO Group Welcomes SGX Group to Capital Table As Shareholder, Expanding Its Blue-Chip Investor Base

SINGAPORE, Sept. 15, 2025 /PRNewswire/ — FOMO Group, a leading fintech group headquartered in Singapore, today announced that SGX Group (Singapore Exchange), Asia’s leading multi-asset exchange, has joined its capital table as shareholder. This marks a significant milestone for FOMO Group, further expanding its blue-chip investor base and reinforcing confidence in the Group’s long-term vision.

FOMO Group’s ecosystem—anchored by FOMO Pay, CapBridge, and 1exchange—offers one-stop financial services in cross-border payment, cross-asset investment, and real-world asset (RWA) tokenization. SGX Group, which invested in CapBridge and 1exchange, has become FOMO Group’s newest shareholder via a share exchange – joining a distinguished lineup of investors backing the Group’s mission to build licensed, next generation financial-technology solutions.

FOMO Group provides last-mile capabilities in digital payments, digital banking, and asset custody. With SGX Group’s strength as a robust capital markets infrastructure, future opportunities can be captured in areas such as digital capital markets infrastructure, the listing and trading of tokenized assets, real-time stablecoin-powered settlement, and cross-border capital-market connectivity.

Louis Liu, Group CEO of FOMO Group, said: “We are excited to welcome SGX Group as our newest shareholder. This represents a vote of confidence in our strategy and an opportunity to collaborate with SGX Group, Asia’s leading and trusted securities and derivatives market infrastructure. SGX Group’s deep expertise in capital markets, combined with our comprehensive digital finance capabilities, will unlock new possibilities for our merchants, corporates, and institutional clients.”

Amit Kedia, Executive Director, Finance and Corporate Development, SGX Group, said: “In a region rapidly embracing digital finance, there is a growing need for innovation that strengthens the trust and resilience of our market infrastructure. This presents opportunities for regulated interoperable solutions that enhance connectivity and efficiency across the ecosystem. FOMO Group is helping to build the foundation for the next generation of digital finance – seamless, secure and borderless financial experiences across the region.” 

FOMO Group remains committed to building trusted, regulated, and interoperable financial solutions that drive business growth across Asia. With SGX Group’s support, the Group is poised to accelerate innovation and deliver greater value across the capital markets and digital finance landscape.

About FOMO Group

Founded in 2015, FOMO Group is a fintech group based in Singapore, offering one-stop digital payment, digital banking, and digital asset solutions, bridging Web 2.0 and Web 3.0 ecosystems. FOMO Group owns three licensed financial institutions which operate independently from each other:

  • FOMO Pay – A major payment institution licensed in Singapore, Hong Kong and the United Arab Emirates, offering global collection and payout solutions. The company provides a one-stop digital payment infrastructure that enables seamless payment operations across fiat currencies and regulated digital assets for merchants, enterprises, and financial institutions.
  • CapBridge – A leading one-stop digital investment platform, offering top-tier funds, digital asset funds, bonds, equities, and insurance products. It provides mass affluent, HNWIs and institutional clients with seamless access to both private and public markets, meeting clients’ diverse asset allocation needs.
  • 1exchange – A licensed, leading exchange for tokenized real-world assets (RWAs). Offering full-stack on-chain infrastructure, the platform enables issuers to tokenize and list enterprise-grade RWAs, while providing investors a trusted gateway to trade and invest in modern digital assets, unlocking global liquidity.

For media inquiries, please contact marketing@fomopay.com.